OLN vs VRTX · rev $6.54B vs P/E 30, rev $12.00B
Olin Corporation (OLN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
OLN currently screens at market cap $2.62B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the OLN and VRTX stock pages for the full models.
Not investment advice.